Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Mathijssen, R.H.J.

Refine Results

Resource Type

Availability

Creation Date

Show more

Author

Show more

Language

Search results

  • RSS Feed
(1 - 24 of 50)

Pages

Individualized dosing patterns in the treatment of older patients with gastrointestinal stromal tumors
Survival of patients with cancer with DPYD variant alleles and dose-individualized fluoropyrimidine therapy
Analysis of serious weight gain in patients using alectinib for ALK-positive lung cancer
CYP3A4*22 genotype-guided dosing of kinase inhibitors in cancer patients
Local recurrence in primary localised resected gastrointestinal stromal tumours
Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer
Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients
Sex differences in patients with gastrointestinal stromal tumours
Response to "Plasma Uracil as a DPD Phenotyping Test: Pre-analytical Handling Matters"
Response to "Plasma Uracil as a DPD Phenotyping Test: Pre-analytical Handling Matters"
Therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study
Genome-Wide Meta-Analysis Identifies Variants in DSCAM and PDLIM3 that correlate with efficacy outcomes in metastatic renal cell carcinoma patients treated with sunitinib
Dihydropyrimidine dehydrogenase phenotyping using pretreatment uracil
UGT1A1 genotype-guided dosing of irinotecan
Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinoma
Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen (vol 184, pg 107, 2020)
Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen
Gastrointestinal stromal tumours (GIST) in young adult (18-40 years) patients
Tumor mutational load, CD8(+) T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients
Blood-based kinase activity profiling
Genetic polymorphisms in ABCG2 and CYP1A2 are associated with imatinib dose reduction in patients treated for gastrointestinal stromal tumors
Therapeutic Drug Monitoring of Oral Anticancer Drugs: The Dutch Pharmacology Oncology Group-Therapeutic Drug Monitoring Protocol for a Prospective Study
Impact of CYP3A4*22 on Pazopanib Pharmacokinetics in Cancer Patients
Comparison of toxicity and effectiveness between fixed-dose and body surface area-based dose capecitabine

Pages